A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinic al trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. ...read more read less